Day One Biopharmaceuticals (NASDAQ: DAWN) Reports Positive Results from its FIREFLY-1 Clinical Trial of Tovorafenib
Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) is engaged as a clinical-stage biopharmaceutical company, which is focused on the research, development ...
